Sharon Nahm
@sharonnahm
Medical oncologist in Sydney, Australia.
PhD candidate - Thinking and Talking about Prognosis in Advanced cancer.
ID: 985386466195877888
15-04-2018 05:16:55
63 Tweet
185 Followers
199 Following
Don't forget to register your interest with COSA to get an Asia Pacific focused Global Oncology group going. A place for PallCare, RadOnc, MedOnc, all Oncs and Allied Health wanting to improve outcome in our region. ausyoungoncs Palliative Care Australia RANZCR Rad Oncology #APROSIG
>25% of ppl receiving ICIs had an emergency presentation and 1 in 3 were due to IRAEs. 40% had previous >G2 IRAEs and 29% required 2L immunosuppression. Excited to share real-world data from The Christie NHS published in the The European Journal of Cancer. authors.elsevier.com/a/1eamd3QE--RV…
Wouldn’t you love to know what this study showed? Fantastic work from YOGAs at Medical Oncology Group of Australia (MOGA) ASM 2022 Sharon Nahm
Such a practical and important tool to have available in the clinic - amazing work Medical Oncology Group of Australia (MOGA) Sharon Nahm Belinda Kiely Martin Stockler
Fabulous to be back at Grand Rounds FTT again with Martin Stockler helping us estimate 3 survival scenarios for patients with advanced cancer. CTC.USYD.edu.au/3scenarios/ Prunella Blinman
Hot off the press in NatureRevClinOncol ! Using examples from trials presented at #ASCO23, in this educational piece, I highlight how we should think about crossover in cancer clinical trials. Such education also forms a core theme of what we do Common Sense Oncology. In this piece, I argue
Ping Abhijit Pal Omali Pitiyarachchi Christina Teng Ben Kong Prunella Blinman Dr Deme Karikios Dr Andrew Parsonson Liz Connolly Melissa Moore Malinda Itchins Ash Malalasekera Peey Sei Kok A/Prof. Shahneen Sandhu Prof Tom John - pls consider completing and sharing with colleagues! 🙏🏾